Mark A. Gardner
SVP of Molecular Gen & Oncol, Quest Diagnostics.
Companies
- GeneDx Holdings Corp.President Jun 16, 2026 to now1
- Quest DiagnosticsSVP of Molecular Gen & Oncol Nov 22, 2022 to Sep 26, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Quest Diagnostics DGX4,673 shares3$1.1M at $234.83Sep 24, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 24, 2024Shares withheld for tax 120 shares at $155.70 of Quest Diagnostics3
- Feb 28, 2024Shares withheld for tax 262 shares at $126.36 of Quest Diagnostics4
- Feb 14, 2024Granted 2,250 shares of Quest Diagnostics5
- Sep 25, 2023Shares withheld for tax 116 shares at $126.22 of Quest Diagnostics6
- Feb 23, 2023Granted 1,919 shares of Quest Diagnostics7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGeneDx Holdings Corp., President
- 2
- 3
- 4SEC EDGARForm 4 filed Mar 1, 2024
- 5SEC EDGARForm 4 filed Feb 16, 2024
- 6SEC EDGARForm 4 filed Sep 27, 2023
- 7SEC EDGARForm 4 filed Feb 27, 2023